Thompson, George R.

Practice Guidelines for the Diagnosis and Management of Aspergillosis: 2016 Update by the Infectious Diseases Society of America

Patterson, T. F., Thompson, G. R., Denning, D. W., Fishman, J. A., Hadley, S., Herbrecht, R., Kontoyiannis, D. P., Marr, K. A., Morrison, V. A., Nguyen, M. H., et al. (2016) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal and yeast genetics research

Cited by 2,926

Isavuconazole versus voriconazole for primary treatment of invasive mould disease caused by Aspergillus and other filamentous fungi (SECURE): a phase 3, randomised-controlled, non-inferiority trial

Maertens, J. A., Raad, I. I., Marr, K. A., Patterson, T. F., Kontoyiannis, D. P., Cornely, O. A., Bow, E. J., Rahav, G., Neofytos, D., Aoun, M., et al. (2016) · The Lancet

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 1,001

The Antifungal Pipeline: Fosmanogepix, Ibrexafungerp, Olorofim, Opelconazole, and Rezafungin

Hoenigl, M., Sprute, R., Egger, M., Arastehfar, A., Cornely, O. A., Krause, R., Lass-Flörl, C., Prattes, J., Spec, A., Thompson, G. R., et al. (2021) · Drugs

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 467

Aspiring Antifungals: Review of Current Antifungal Pipeline Developments

Gintjee, T., Donnelley, M., & Thompson, G. (2020) · Journal of Fungi

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 225

Breakthrough invasive fungal infections: Who is at risk?

Jenks, J. D., Cornely, O. A., Chen, S. C. ‐., Thompson, G. R., & Hoenigl, M. (2020) · Mycoses

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 191

Detecting Infections Rapidly and Easily for Candidemia Trial, Part 2 (DIRECT2): A Prospective, Multicenter Study of the T2Candida Panel

Clancy, C. J., Pappas, P. G., Vazquez, J., Judson, M. A., Kontoyiannis, D. P., Thompson, G. R., Garey, K. W., Reboli, A., Greenberg, R. N., Apewokin, S., et al. (2018) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 165

Rezafungin versus caspofungin in a phase 2, randomized, double-blind study for the treatment of candidemia and invasive candidiasis: the STRIVE Trial

Thompson, G. R., Soriano, A., Skoutelis, A., Vazquez, J. A., Honore, P. M., Horcajada, J. P., Spapen, H., Bassetti, M., Ostrosky-Zeichner, L., Das, A. F., et al. (2021) · Clinical Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 163

Invasion of the Central Nervous System by Cryptococcus neoformans Requires a Secreted Fungal Metalloprotease

Vu, K., Tham, R., Uhrig, J. P., Thompson, G. R., Na Pombejra, S., Jamklang, M., Bautos, J. M., & Gelli, A. (2014) · mBio

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 159

Cryptococcus gattii in North American Pacific Northwest: whole-population genome analysis provides insights into species evolution and dispersal

Engelthaler, D. M., Hicks, N. D., Gillece, J. D., Roe, C. C., Schupp, J. M., Driebe, E. M., Gilgado, F., Carriconde, F., Trilles, L., Firacative, C., et al. (2014) · mBio

Fungal Infections and StudiesGenetic diversity and population structure

Cited by 133

Coccidioidomycosis Acquired in Washington State

Marsden-Haug, N., Goldoft, M., Ralston, C., Limaye, A. P., Chua, J., Hill, H., Jecha, L., Thompson, G. R., & Chiller, T. (2013) · Clinical Infectious Diseases

Fungal Infections and StudiesActinomycetales infections and treatment

Cited by 126

Epidemiology of Invasive Candidiasis

Bays, D., Jenkins, E., Lyman, M., Chiller, T., Strong, N., Ostrosky-Zeichner, L., Hoenigl, M., Pappas, P., & Thompson, G. (2024) · Clinical Epidemiology

Antifungal resistance and susceptibilityYeasts and Rust Fungi Studies

Cited by 109

Ibrexafungerp: A novel oral glucan synthase inhibitor

Davis, M. R., Donnelley, M. A., & Thompson, G. R. (2020) · Medical Mycology

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 91

Mycotic Infections Acquired outside Areas of Known Endemicity, United States

Benedict, K., Thompson, G. R., Deresinski, S., & Chiller, T. (2015) · Emerging Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 89

MSG-10: a Phase 2 study of oral ibrexafungerp (SCY-078) following initial echinocandin therapy in non-neutropenic patients with invasive candidiasis

Spec, A., Pullman, J., Thompson, G. R., Powderly, W. G., Tobin, E. H., Vazquez, J., Wring, S. A., Angulo, D., Helou, S., Pappas, P. G., et al. (2019) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 88

Let’s talk about sex characteristics—as a risk factor for invasive fungal diseases.

Egger, M., Hoenigl, M., Thompson, G. R., Carvalho, A., & Jenks, J. D. (2022) · Mycoses

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 82

Wildfire smoke, a potential infectious agent

Kobziar, L. N., & Thompson, G. R. (2020) · Science

Indoor Air Quality and Microbial ExposureAir Quality and Health Impacts

Cited by 78

A Mycoses Study Group International Prospective Study of Phaeohyphomycosis: An Analysis of 99 Proven/Probable Cases.

Revankar, S. G., Baddley, J. W., Chen, S. C. A., Kauffman, C. A., Slavin, M., Vazquez, J. A., Seas, C., Morris, M. I., Nguyen, M. H., Shoham, S., et al. (2017) · Open Forum Infectious Diseases

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 67

Rezafungin: a novel antifungal for the treatment of invasive candidiasis

Ham, Y. Y., Lewis, J. S., & Thompson, G. R. (2021) · Future Microbiology

Antifungal resistance and susceptibilityFungal Plant Pathogen Control

Cited by 66

Clinical safety and efficacy of novel antifungal, fosmanogepix, for the treatment of candidaemia: results from a Phase 2 trial

Pappas, P. G., Vazquez, J. A., Oren, I., Rahav, G., Aoun, M., Bulpa, P., Ben-Ami, R., Ferrer, R., Mccarty, T., Thompson, G. R., et al. (2023) · Journal of Antimicrobial Chemotherapy

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 65

An update on current and novel molecular diagnostics for the diagnosis of invasive fungal infections

Jenks, J. D., White, P. L., Kidd, S. E., Goshia, T., Fraley, S. I., Hoenigl, M., & Thompson, G. R. (2023) · Expert Review of Molecular Diagnostics

Antifungal resistance and susceptibilityBacterial Identification and Susceptibility Testing

Cited by 61

Race and ethnicity: Risk factors for fungal infections?

Jenks, J. D., Aneke, C. I., Al-Obaidi, M. M., Egger, M., Garcia, L., Gaines, T., Hoenigl, M., & Thompson, G. R. (2023) · PLOS Pathogens

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 55

In vivo development of fluconazole resistance in serial Cryptococcus gattii isolates from a cat

Sykes, J. E., Hodge, G., Singapuri, A., Yang, M. L., Gelli, A., & Thompson, G. R. (2016) · Medical Mycology

Fungal Infections and StudiesAntifungal resistance and susceptibility

Cited by 13

1718. Rezafungin Clinical Safety and Efficacy in Patients With Candidemia and/or Invasive Candidiasis in the Randomized, Double-Blind, Multicenter, Phase 2 STRIVE Study

Thompson, G. R., Vazquez, J., Soriano, A., Skoutelis, A., Ostrosky-Zeichner, L., Mena, K., Navalta, L., Sandison, T., & Pappas, P. (2018) · Open Forum Infectious Diseases

Antifungal resistance and susceptibilityFungal Infections and Studies

Cited by 5